APTOCROM Inc. (KOSDAQ: A109960)
Health Care · Biotechnology · KR
₩1,821.00
-5.50% today · -70.2% 1Y
APTOCROM Inc. (KOSDAQ: A109960) operates in the Biotechnology industry within the Health Care sector. The company is valued at $20.66M.
Over the last twelve months the share price has lost 70.2%, trading between 1.43K and 6.60K.
Tweenvest scores APTOCROM Inc. across four factors: quality 56/100, value 64/100, growth 0/100. Its strongest factor is value.
A109960 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $20.66M
- Revenue (TTM)
- $6.96M
- P/E
- 0.55
- EPS
- 3,297.09
- Dividend yield
- —
- Beta (5Y)
- -0.10
- 52-week high
- ₩6,600.00
- 52-week low
- ₩1,430.00
- Avg volume (3M)
- —
- Shares outstanding
- 15.13M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| genOway Société anonymeENXTPA: ALGEN | $22.30M | €2.15 | -3.59% |
| Nanollose LimitedASX: NC6 | $21.63M | AU$0.08 | -1.30% |
| Helyx Industries S.p.A.BIT: HLX | $20.77M | €0.70 | -7.67% |
| SkinBioTherapeutics plcAIM: SBTX | $20.74M | £0.06 | +12.15% |
| ProBiotix Health PlcOFEX: PBX | $20.57M | £0.10 | +2.63% |
| Taiwan Advance Bio-Pharmaceutical Inc.TPEX: 4186 | $20.25M | NT$7.30 | -3.31% |
| BCAL Diagnostics LimitedASX: BDX | $20.15M | AU$0.08 | -12.22% |
| MDxHealth SANasdaqCM: MDXH | $19.71M | $0.21 | -64.97% |
Figures last refreshed Oct 18, 2026.